ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ÖܼÎÓ±£©¿ÚÇ»ÁÛ°©ÊÇÍ·¾±²¿³£¼ûµÄ¶ñÐÔÖ×ÁöÖ®Ò»£¬£¬¾Ö²¿·¦ÑõºÍÃâÒßÒÖÖÆÊÇ¿ÚÇ»ÁÛ°©Í¨ÀýÖÎÁÆÐ§¹û²»¼ÑµÄÖ÷ÒªÔÒò¡£½üÄêÀ´Ê¹ÓùâÃô¼ÁÔÚÌØ¶¨²¨³¤¹âÕÕÉäºóÌìÉúÑÄÐÔÑõ£¨ROS£©É±ÉËÖ×Áöϸ°ûµÄ¹â¶¯Á¦ÁÆ·¨£¨PDT£©ÔÚÁÙ´²È¡µÃÒ»¶¨Ð§¹û£¬£¬µ«¹Å°åPDTÒ©ÎïµÄ¸ßÑõÒÀÀµÐÔÏÞÖÆÆä½øÒ»²½ÆÕ±éÓ¦Óá£
2022Äê8Ô£¬£¬ngµç×ÓÓÎÏ·Á¥Êô¿ÚǻҽԺÎâÍ©¸±Ö÷ÈÎҽʦ¡¢¡¢³Ì±ó½ÌÊÚÍŶÓÁªºÏngµç×ÓÓÎÏ·»¯Ñ§Ñ§ÔºµÄÌ·²ÊƼ½ÌÊÚ¡¢¡¢Ã«×ÚÍò½ÌÊÚÍŶÓÔÚBiomaterialsÔÓÖ¾½ÒÏþÁËÌâΪ¡°Ru(II)-modified TiO2 nanoparticles for hypoxia-adaptive photo-immunotherapy of oral squamous cell carcinoma¡±µÄÑо¿ÂÛÎÄ¡£ÎªÕ½Ê¤PDTÒ©Îï·¦ÑõÏÞÖÆµÄÍ´µã£¬£¬¸ÃÑо¿Ê¹ÓÃîÉ£¨II£©ÅäºÏÎRu£©ÐÞÊζþÑõ»¯îÑ£¨TiO2£©ÄÉÃ×Á£×Ó£¬£¬½øÒ»²½¸ºÔØÈ±ÑõÓÕµ¼Òò×ÓHIF-1¦Á siRNA£¬£¬ÖƵÃÒ»ÖÖÐÂÐ͹⶯Á¦ÄÉÃ׿ÅÁ£TiO2@Ru@siRNA¡£Ôڿɼû¹âÕÕÉäÏ£¬£¬¸ÃÄÉÃ׿ÅÁ£ÄÜÏÔÖøÉϵ÷ϸ°ûROSˮƽ£¬£¬ÓÕµ¼Ï¸°û½¹Íö£»£»£»Í¨¹ý½éµ¼ÈÜøÌåËðÉË£¬£¬´ÙʹHIF-1¦Á siRNAÌÓÒÝ£¬£¬¸ÄÉÆÖ×Áö¾Ö²¿·¦Ñõ״̬¡£Í¬Ê±¸ÃÄÉÃ׿ÅÁ£Í¨¹ýHMGB1-NF-KB-PDL1Öáϵ÷Ö×Áöϸ°ûPDL1ˮƽ£¬£¬Ôö½ø¿¹Ö×Áöϸ°ûÒò×ÓIL-24ÉøÍ¸ÔöÌí£¬£¬¼¤»îCD4+ºÍCD8+ Tϸ°û£¬£¬ÖØËֲܾ¿ÃâÒß΢ÇéÐΡ£ÔÚ4NQOÓÕµ¼µÄ´óÊóÉà°©Ä£×ÓºÍÈËÔ´ÒìÖÖÒÆÖ²Áö£¨PDX£©Ð¡ÊóÄ£×ÓÖУ¬£¬TiO2@Ru@siRNA×èÖ¹ÉÏÆ¤¶ñÐÔת»¯£¬£¬ÔöÇ¿¾Ö²¿ÃâÒߣ¬£¬ÒÖÖÆÖ×ÁöÉú³¤µÄЧ¹û¾ù»ñµÃ½øÒ»²½ÑéÖ¤¡£×ÛÉÏ£¬£¬¸ÃÐÂÐÍÄÉÃ׿ÅÁ£TiO2@Ru@siRNAÄܹ»¸ÄÉÆÖ×Áö¾Ö²¿·¦Ñõ״̬£¬£¬±¬·¢½ÏÇ¿µÄ¹â¶¯Á¦Ð§Ó¦£¬£¬Í¬Ê±ÖØËֲܾ¿ÃâÒßÒÖÖÆÎ¢ÇéÐΣ¬£¬ÔöÇ¿Ö×ÁöɪË×÷Ó᣻£»£»ùÓÚ¸ÃÄÉÃ׿ÅÁ£µÄ¹âÃâÒßÖÎÁÆÕ½ÂÔΪ¿ÚÇ»ÁÛ°©µÄ·ÀÖÎÌṩÁËÒ»ÖÖÐÂÕ½ÂÔ¡£

TiO2@Ru@siRNAÄÉÃ׿ÅÁ£º£º£ºÏ³É¼°½éµ¼¿ÚÇ»ÁÛ°©¹âÃâÒßÖÎÁÆÄ£Ê½Í¼
¸ÃÏîÊÂÇé»ñµÃÁ˹ãÖÝÊпƼ¼ÍýÏëÏîÄ¿ºÍ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÖ§³Ö¡£ÎâÍ©¸±Ö÷ÈÎҽʦ¡¢¡¢Ì·²ÊƼ½ÌÊÚ¡¢¡¢³Ì±ó½ÌÊÚ¡¢¡¢Ã«×ÚÍò½ÌÊÚΪ±¾ÎĵÄÅäºÏͨѶ×÷Õß¡£ÖܼÎÓ±£¨²©Ê¿Ñо¿Éú£©¡¢¡¢ÍôÎĽõ²©Ê¿¡¢¡¢Õų¿Ó꣨˶ʿÑо¿Éú£©¡¢¡¢ÁèîÚâù£¨²©Ê¿Ñо¿Éú£©£¬£¬Îª±¾ÎĵÄÅäºÏµÚÒ»×÷Õß¡£
ÂÛÎÄÁ´½Ó£º£º£ºhttps://doi.org/10.1016/j.biomaterials.2022.121757